EPA selects Phylonix to screen compound library in zebrafish

Cambridge, MA April 12, 2007 -- Phylonix Pharmaceuticals, Inc. today announced it has been awarded a major, two-year contract for up to $4.3 million by the Environmental Protection Agency (EPA) as part of the agencys ToxCast project to correlate compounds having known toxicities with biological activities in a zebrafish test system.

"We are very pleased that the EPA has chosen Phylonix to participate in the ToxCast project because it validates our significant capabilities and the superior quality of our eZ-ScreensTM zebrafish-based assays," stated Patricia McGrath, Phylonix President and Chief Executive Officer. "The ToxCast award is further confirmation that this model organism can be used to predict compound effects in humans. In addition, the contract will complement our work performed for the pharmaceutical industry to assess toxicity and efficacy for preclinical studies."

The EPA is exploring the use of zebrafish as a screening tool to complement the biochemical, cellular, genomic and metabolomic assays that will be the basis of the ToxCast project being developed by the agency for use in prioritization of potential environmental toxicants for further study. The National Center for Computational Toxicology (NCCT) of the Office and Research and Development of EPA has made multi-year awards to eight companies, including Phylonix, for the generation of High Throughput Screening (HTS) data in support of the ToxCast program. It is estimated there are more than 10,000 environmental chemicals from EPA programs that need prioritizing for further testing.

There is considerable interest in using zebrafish as a model organism of vertebrate biology because of the accessibility of their central nervous system, digestive system, and cardiovascular system to functional study during compound exposure in relatively high-throughput format. All essential components of vertebrate form and organ development are mimicked in the transparent zebrafish and

Contact: Edward O'Lear

Page: 1 2

Related biology news :

1. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
2. OneWorld Health selects Odyssey Research for phase 4 study in India
3. NIH selects Childrens Hospital as Center of Excellence to train future generations of scientists
4. NIH selects Purdue to use phi29 DNA packaging motor for National Nanomedicine Development Center
5. IUBMB selects Wiley to publish Biochemistry and Molecular Biology Education
6. NIH selects Pittsburgh institute as leader for HIV/AIDS prevention efforts
7. EMBO selects Europes best young independent scientists
8. NIH selects Burnham Institute for Exploratory Center for Human Embryonic Stem Cell Research
9. NHGRI selects 13 new targets for large-scale sequencing program
10. Phylonix awarded National Science Foundation Phase II SBIR for zebrafish screening
11. ACMG recognizes progress made in newborn screening

Post Your Comments:

(Date:7/2/2020)... ... July 02, 2020 , ... Dutch ... the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 ... The article, titled "Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2," ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... today announced that it has entered into a multi-year contract with Merus ... support their translational and clinical research strategy to discover and develop ground-breaking ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... antibody development services, today announced that the company has received ISO9001:2015 certification ... pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/10/2020)... LEXINGTON, Mass. (PRWEB) , ... July 09, 2020 ... ... novel approaches to cell therapy, today announced the hiring of Allen R. Nissenson, ... executive team and oversee the clinical development of Sentien’s lead product, SBI-101. ...
(Date:7/1/2020)... ... 29, 2020 , ... MedShift , a leading medical ... many obstacles created as a result of COVID-19. As a provider at the ... practices and medical manufacturers by expanding access to device offerings, technology services, and ...
Breaking Biology Technology:
Cached News: